Bmnp Antimonium Tartaricum (antimonium tartaricum) NDC 82969-5231

NDC codes

FDA NDC Directory

Product NDC (as listed)82969-5231Labeler and product segments. Claims need a package NDC.

Product NDC at billing width82969-5231Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
82969-5231-1	82969523101	25 g in 1 BOTTLE, GLASS (82969-5231-1)Marketed from Jun 1, 2026
82969-5231-2	82969523102	8 g in 1 BOTTLE, GLASS (82969-5231-2)Marketed from Jun 1, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bmnp Antimonium Tartaricum
Generic name (nonproprietary): antimonium tartaricum
Active ingredients: Tartar emetic — 30 [hp_C]/g
Dosage form: Globule
Route: Oral
Labeler: Total Operations Management LLC DBA:Bestmade Natural Products Micro
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Jun 1, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 82969-5231_5a6a8766-19c2-0688-e063-6394a90a60d0SPL ID 5a6a8766-19c2-0688-e063-6394a90a60d0SPL set ID 5a6a889c-e975-06e2-e063-6394a90ac02dUNII DL6OZ476V3

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482969523101 followed by a unit qualifier and the quantity

Package 82969-5231-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 1, 2026.

Indications (excerpt from the label)

Helps temporarily relieve: congestion, cough, weakness, respiratory discomfort

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)